<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862292</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1337</article-id><article-id pub-id-type="other">EPV0688</article-id><article-id pub-id-type="pii">S0924933824013373</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Are antipsychotics carcinogenic?: A review of the literature</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Walha</surname><given-names>S.</given-names></name><xref rid="aff2964" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Mezri</surname><given-names>D.</given-names></name><xref rid="aff2964" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Mahfoudh</surname><given-names>K.</given-names></name><xref rid="aff2964" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Hamzaoui</surname><given-names>S.</given-names></name><xref rid="aff2964" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Ouertani</surname><given-names>A.</given-names></name><xref rid="aff2964" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Ouali</surname><given-names>U.</given-names></name><xref rid="aff2964" ref-type="aff"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Aissa</surname><given-names>A.</given-names></name><xref rid="aff2964" ref-type="aff"/><xref rid="cor1188" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Jomli</surname><given-names>R.</given-names></name><xref rid="aff2964" ref-type="aff"/></contrib></contrib-group><aff id="aff2964">&#x0201d;Psychiatry A&#x0201d;, <institution>Razi Hospital</institution>, <city>Manouba</city>, <country>Tunisia</country></aff><author-notes><corresp id="cor1188"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1312">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S645</fpage><lpage>S645</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824013373a.pdf"/><abstract><sec id="sec7141"><title>Introduction</title><p>Antipsychotics are currently widely prescribed for various mental disorders. A presumption of a potential carcinogenic effect of antipsychotics was raised by certain studies. There are few data in the literature on this subject.</p></sec><sec id="sec7142"><title>Objectives</title><p>Study the relationship between the use of antipsychotics and the risk of cancer.</p></sec><sec id="sec7143"><title>Methods</title><p>A systematic literature review was carried out on PubMed looking for articles in English, published during the last decade (2013-2023), using the keywords &#x0201c;Antipsychotics&#x0201d; and &#x0201c;Cancer&#x0201d;. We included all articles studying the relationship between antipsychotics use and cancer risk.</p></sec><sec id="sec7144"><title>Results</title><p>
Nine articles were included in our study, the majority of which focused on breast cancer. The results regarding breast cancer were discordant: although three studies did not show an association between the administration of antipsychotics and breast cancer, more recent studies have proven the opposite. Indeed, chronic exposure to antipsychotics, particularly those raising prolactinemia, was significantly associated with an accumulated risk of breast cancer, especially with positive estrogen receptors, whereas prolactin-sparing antipsychotics were not associated with it. Regarding hematologic malignancies, unlike other antipsychotics, long-term use of clozapine was associated with a high risk of malignancy, and had a greater effect on mortality from lymphoma and leukemia than to agranulocytosis. On the other hand, it has been proven that the use of atypical antipsychotics is associated with a reduced risk of lung cancer.</p></sec><sec id="sec7145"><title>Conclusions</title><p>Data from the literature regarding the carcinogenic potential of antipsychotics remain discordant and inconclusive. The most recent studies are worrying and highlight in particular an association between the use of antipsychotics and the increased risk of breast cancer. If these data are confirmed in future studies, this will undoubtedly impact the benefit-risk balance when making therapeutic decisions.</p></sec><sec id="sec7146"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>